rdf:type |
|
lifeskim:mentions |
umls-concept:C0007589,
umls-concept:C0017262,
umls-concept:C0027651,
umls-concept:C0185117,
umls-concept:C0439849,
umls-concept:C0812309,
umls-concept:C1334129,
umls-concept:C1511938,
umls-concept:C2239176,
umls-concept:C2261558,
umls-concept:C2911684
|
pubmed:issue |
12
|
pubmed:dateCreated |
2003-1-13
|
pubmed:abstractText |
Inhibitor of growth-1 (ING1) is a new candidate for the tumour suppressor gene that encodes a 33k Da protein (p33(ING1)). While reduction of p33(ING1) is an important event in some human cancers, the expression of p33(ING1) in human hepatocellular carcinoma (HCC) remains to be examined. We evaluated p33(ING1) expression in various liver diseases including HCC.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cell Cycle Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin E,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Growth Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/ING1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Intracellular Signaling Peptides...,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0036-5521
|
pubmed:author |
pubmed-author:FunakiTT,
pubmed-author:KuriyamaSS,
pubmed-author:KurokohchiKK,
pubmed-author:MasalaCC,
pubmed-author:MiyauchiYY,
pubmed-author:MorishitaAA,
pubmed-author:NagaiMM,
pubmed-author:NakaiSS,
pubmed-author:OhgiTT,
pubmed-author:WatanabeSS,
pubmed-author:YukimasaSS
|
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1440-8
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:12523595-Blotting, Western,
pubmed-meshheading:12523595-Carcinoma, Hepatocellular,
pubmed-meshheading:12523595-Cell Cycle Proteins,
pubmed-meshheading:12523595-Cyclin E,
pubmed-meshheading:12523595-Cyclin-Dependent Kinases,
pubmed-meshheading:12523595-DNA-Binding Proteins,
pubmed-meshheading:12523595-Female,
pubmed-meshheading:12523595-Genes, Tumor Suppressor,
pubmed-meshheading:12523595-Growth Inhibitors,
pubmed-meshheading:12523595-Humans,
pubmed-meshheading:12523595-Immunohistochemistry,
pubmed-meshheading:12523595-Intracellular Signaling Peptides and Proteins,
pubmed-meshheading:12523595-Liver,
pubmed-meshheading:12523595-Liver Neoplasms,
pubmed-meshheading:12523595-Male,
pubmed-meshheading:12523595-Middle Aged,
pubmed-meshheading:12523595-Nuclear Proteins,
pubmed-meshheading:12523595-Proteins,
pubmed-meshheading:12523595-Tumor Suppressor Proteins
|
pubmed:year |
2002
|
pubmed:articleTitle |
Expression of p33(ING1) in hepatocellular carcinoma: relationships to tumour differentiation and cyclin E kinase activity.
|
pubmed:affiliation |
Third Dept. of Internal Medicine, Kagawa Medical University, Miki-cho, Kita-gun, Kagawa, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|